These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 59781)

  • 21. Hemolytic activity of leukemic sera: the role of complement and sucrose.
    Berchtold PE; Spaeth PJ; Haeberli A; Straub PW
    J Lab Clin Med; 1986 Jun; 107(6):544-50. PubMed ID: 3086472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.
    Rao AK; Schmaier AH; Colman RW
    Pathobiol Annu; 1982; 12():35-64. PubMed ID: 6186978
    [No Abstract]   [Full Text] [Related]  

  • 23. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.
    Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE
    Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute pancreatitis in man. A clinical and biochemical study of pathophysiology and treatment.
    Lasson A
    Scand J Gastroenterol Suppl; 1984; 99():1-57. PubMed ID: 6205440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma inhibitors of the components of the fibrinolytic pathway in man.
    Schreiber AD; Kaplan AP; Austen KF
    J Clin Invest; 1973 Jun; 52(6):1394-401. PubMed ID: 4122174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Physiologic inhibitors of blood coagulation. 2. Alpha 2-macroglobulin, alpha-antitrypsin and the C1 inhibitor of complement].
    Kase F; Pospísil J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):634-50. PubMed ID: 6198247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of heparin on the activation of factor XII and the contact system in plasma.
    Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
    Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the alternative complement pathway in systemic lupus erythematosus.
    Wilson MR; Arroyave CM; Nakamura RM; Vaughan JH; Tan EM
    Clin Exp Immunol; 1976 Oct; 26(1):11-20. PubMed ID: 826360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cold activation of complement and kinin.
    Kondo M; Takemura S; Yoshikawa T; Kato H; Yokoe N; Ikezaki M; Hosokawa K; Masuda M
    Adv Exp Med Biol; 1979; 120B():133-8. PubMed ID: 117680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case report of hereditary angioedema and studies on the serum components of complement, C1-inactivator and proteinase inhibitors during edema attack].
    Mikami A; Kohno M
    Hokkaido Igaku Zasshi; 1987 May; 62(3):497-500. PubMed ID: 3610041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation.
    Wachtfogel YT; Bischoff R; Bauer R; Hack CE; Nuijens JH; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
    Thromb Haemost; 1994 Dec; 72(6):843-7. PubMed ID: 7740452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The difference between serum and plasma complement activity in primary renal disease.
    Akagaki Y; Fujiwara Y; Nakanishi I; Orita Y; Ando A; Abe H; Kitamura H; Nagaki K; Inai S
    Clin Nephrol; 1980 Aug; 14(2):75-80. PubMed ID: 7408259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonparticipation of C1q in the decrease of complement activity in the cold in sera of patients with chronic liver diseases.
    Yoshida H; Morito T; Onizawa N; Kasukawa R
    Int Arch Allergy Appl Immunol; 1980; 62(4):433-41. PubMed ID: 6247290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.
    Saito H; Ratnoff OD; Marshall JS; Pensky J
    J Clin Invest; 1973 Apr; 52(4):850-61. PubMed ID: 4266422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.
    Jaffe CJ; Atkinson JP; Frank MM
    J Clin Invest; 1976 Oct; 58(4):942-9. PubMed ID: 965497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibition of activated factor XII (Hageman factor) by antithrombin III: the effect of other plasma proteinase inhibitors.
    Chan JY; Burrowes CE; Habal FM; Movat HZ
    Biochem Biophys Res Commun; 1977 Jan; 74(1):150-8. PubMed ID: 65173
    [No Abstract]   [Full Text] [Related]  

  • 37. Haemolytic complement, anticomplementry activity and hepatitis B antigen in sera of patients with cirrhosis of the liver.
    Kelkar SS; Karhade NV; Kotwal SE
    Indian J Med Res; 1975 Jan; 63(1):41-4. PubMed ID: 1213709
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum protein profiles in thermal burns. II. Protease inhibitors, complement factors, and c-reactive protein.
    Daniels JC; Larson DL; Abston S; Ritzmann SE
    J Trauma; 1974 Feb; 14(2):153-62. PubMed ID: 4130044
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on coagulation and fibrinolysis in pregnancy, with special reference to cold activation of factor VII.
    Gjonnaess H; Fagerhol MK
    Acta Obstet Gynecol Scand; 1975; 54(4):363-7. PubMed ID: 1081809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protease inhibitors and the distal lung.
    Talamo RC
    Ann N Y Acad Sci; 1974; 221():234-7. PubMed ID: 4132120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.